Class | Drug name | n11 | n1+ | ROR (95%CI) | IC (95%CI) |
---|---|---|---|---|---|
GLP-1-RAs | (ALL) | 36 | 429 | 5.61* (3.95–7.96) | 2.17* (1.66–2.67) |
dulaglutide | 1 | 20 | 3.08 (0.41–23.04) | 0.56 (−1.57–2.70) | |
exenatide | 19 | 122 | 11.08* (6.75–18.18) | 2.70* (2.00–3.41) | |
liraglutide | 15 | 278 | 3.39* (2.00–5.74) | 1.49* (0.74–2.24) | |
lixisenatide | 1 | 12 | 5.32 (0.69–41.28) | 0.71 (− 1.48–2.91) | |
DPP-4-Is | (ALL) | 31 | 3276 | 0.54 (0.37–0.77) | -0.81 (− 1.34 – −0.29) |
alogliptin | 1 | 345 | 0.17 (0.02–1.20) | − 1.77 (−3.82–0.28) | |
anagliptin | 0 | 72 | – | – | |
linagliptin | 4 | 332 | 0.71 (0.26–1.91) | −0.40 (−1.71–0.90) | |
omarigliptin | 0 | 2 | – | – | |
saxagliptin | 0 | 70 | – | – | |
sitagliptin | 16 | 1181 | 0.80 (0.48–1.31) | −0.30 (−1.01–0.41) | |
teneligliptin | 0 | 98 | – | – | |
trelagliptin | 1 | 19 | 3.25 (0.43–24.39) | 0.58 (−1.56–2.72) | |
vildagliptin | 9 | 1189 | 0.44 (0.23–0.85) | −1.07 (−2.00 – −0.15) |